Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ORGANIZATION
ORGANIZATION
- JSGM President Calls for Generic Share Target of 80% by FY2020
March 12, 2015
- Medwatcher Accuses HPV Vaccine Makers of Violating JPMA’s Promotion Code
March 2, 2015
- JPMA to Inform Medical Institutions of New R&D Cost Disclosure Plan in April
February 20, 2015
- AJMC Announces Guidelines for Investigator-Led Clinical Trials
February 20, 2015
- PhRMA Sets to Make Direct Plea to Finance Minister to Drop Annual Price Cut Plan
February 6, 2015
- Number of Contract Sales Reps Increased to 4,148 as of Oct. 2014: CSO Association
February 4, 2015
- JPWA President Reiterates Opposition to Annual NHI Price Revisions
February 2, 2015
- IMI, WADA Sign MOU to Prevent Use of Experimental Drugs for Doping
January 30, 2015
- July-Sept. Generic Share Reaches 51.3% under New Formula: JGA
January 30, 2015
- JPMA Draft Guidelines Urge Companies to Separate Ad Reviewing Bodies from Sales Units
January 27, 2015
- Chuikyo Members Divided on Usage of Savings from NHI Price Cuts
January 26, 2015
- 3-Price Bracket Rule for Generics Causing Various Distortions, Problems: JGA President
January 23, 2015
- Ihoken Proposes New Pricing Rule for Regenerative Medicines
January 22, 2015
- Some LDP Members Keen to Tackle Kampo NHI Price Problem
January 21, 2015
- JSMI to Announce in May a “Grand Design” for OTC Drug Industry
January 21, 2015
- JPMA Notifies of Unfavorable Expressions for Disease Awareness Ads
January 16, 2015
- Pharma Leader Nakayama Hails Tax Plan, Says His New Year Remarks Misleading
January 15, 2015
- Wholesalers Must Revamp Biz Model to Cope with Change in Sales Mix: JPWA Chief
January 14, 2015
- Price Grouping Rule Triggered “Distortion” in Generic Market: JGA President
January 9, 2015
- Pharma Biz Leader Airs Concern over Effective Tax Hikes
January 8, 2015
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…